See above the fascinating presentations by Dr. Anna Wexler, Dr. Karen Rommelfanger and Jacqueline Studer on privacy and ethics during the 2019 SharpBrains Virtual Summit.
We still lack clear standards and taxonomies for neurotechnology but several initiatives are underway to anticipate and address the challenges. One important take-away is that it is important to be aspirational and pragmatic rather than “legalistic” — by considering diverse policy and industry perspectives, striving for the widest benefit with the minimum risks, and better educating users, we can enable beneficial innovation in ways that regulation alone –as important as it is– cannot. [Read more…] about Will better neurotech regulations be enough to address privacy, effectiveness and potential harm concerns?